benzimidazole has been researched along with Carcinoma, Hepatocellular in 5 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hepatocellular carcinoma was the most sensitive cell line towards the tested compounds and 8e was the most potent one on HepG2 cells with an IC50 value of 5." | 5.51 | Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma. ( Dadashpour, S; Ercan, A; Hosseinimehr, SJ; Irannejad, H; Küçükkılınç, TT; Naderi, N, 2019) |
| "Hepatocellular carcinoma was the most sensitive cell line towards the tested compounds and 8e was the most potent one on HepG2 cells with an IC50 value of 5." | 1.51 | Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma. ( Dadashpour, S; Ercan, A; Hosseinimehr, SJ; Irannejad, H; Küçükkılınç, TT; Naderi, N, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dadashpour, S | 1 |
| Küçükkılınç, TT | 1 |
| Ercan, A | 1 |
| Hosseinimehr, SJ | 1 |
| Naderi, N | 1 |
| Irannejad, H | 1 |
| Suk, FM | 1 |
| Liu, CL | 1 |
| Hsu, MH | 1 |
| Chuang, YT | 1 |
| Wang, JP | 1 |
| Liao, YJ | 1 |
| Xie, Q | 1 |
| Liu, S | 1 |
| Li, X | 1 |
| Wu, Q | 1 |
| Luo, Z | 1 |
| Fu, X | 1 |
| Cao, W | 1 |
| Lan, G | 1 |
| Li, D | 2 |
| Zheng, W | 1 |
| Chen, T | 1 |
| Song, WJ | 1 |
| Lin, QY | 1 |
| Jiang, WJ | 1 |
| Du, FY | 1 |
| Qi, QY | 1 |
| Wei, Q | 1 |
| Liu, L | 1 |
| Zhang, H | 1 |
| Meng, X | 1 |
| Yin, J | 1 |
| Liu, C | 1 |
5 other studies available for benzimidazole and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Benzimidazoles; Benzoxazoles; Carcinoma, Hepatocellular; Cell Proliferation; | 2019 |
Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma.
Topics: Animals; Benzimidazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferat | 2019 |
Dinuclear zinc(II) complexes containing (benzimidazol-2-yl)benzene that overcome drug resistance in hepatocellular carcinoma cells through induction of mitochondria fragmentation.
Topics: Adenosine Triphosphate; Apoptosis; Benzene; Benzimidazoles; Carcinoma, Hepatocellular; Coordination | 2014 |
Synthesis, interaction with DNA and antiproliferative activities of two novel Cu(II) complexes with norcantharidin and benzimidazole derivatives.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, | 2015 |
Dinuclear metal(II) complexes of polybenzimidazole ligands as carriers for DNA delivery.
Topics: Benzimidazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Cobalt; Copper; DNA; Drug Carriers; Hum | 2010 |